Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib

by Himisha Beltran, Gurveen Kaur, Carmen Garcías de España, Scott T Tagawa
Published 2014-08-01

Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain

by Luis Cordero Puentes, Carlota Moya de Alarcón, David Carcedo, Jordi Ginés Rubió, Maria del Carmen Garcías de España, Laura Delgado-Ortega
Published 2018-05-01